PCRX Pacira BioSciences PE ratio, current and historical analysis
- Stocks
- Healthcare
- NASDAQ: PCRX
- PE Ratio
The current PE ratio of PCRX can't be determined, as the TTM EPS of -$2.77 is negative. The last PE ratio of Pacira BioSciences, recorded in June 2024, was 20.88.
PCRX PE ratio history
The PE ratio of Pacira BioSciences has averaged 201.14 over the last ten years. Over the past ten years, PCRX's PE ratio was at its highest in the Dec 2015 quarter at 1,535.8, when the stock price was $76.79 and the EPS was $0.05. The lowest value was in the Jun 2021 quarter, when it reached 15.09 with a price of $60.68 and an EPS of $4.02.
Pacira BioSciences PE ratio by year
Maximum annual increase: 260.91% in 2021
Maximum annual decrease: -66.39% in 2023
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| 2024 | N/A | N/A | $18.84 | -$2.15 |
| 2023 | 37.08 | -66.39% | $33.74 | $0.91 |
| 2022 | 110.31 | 74.16% | $38.61 | $0.35 |
| 2021 | 63.34 | 260.91% | $60.17 | $0.95 |
| 2020 | 17.55 | N/A | $59.84 | $3.41 |
| 2019 | N/A | N/A | $45.3 | -$0.27 |
| 2018 | N/A | N/A | $43.02 | -$0.01 |
| 2017 | N/A | N/A | $45.65 | -$1.07 |
| 2016 | N/A | N/A | $32.3 | -$1.02 |
| 2015 | 1,535.8 | N/A | $76.79 | $0.05 |
| 2014 | N/A | N/A | $88.66 | -$0.39 |
| 2013 | N/A | N/A | $57.49 | -$1.93 |
| 2012 | N/A | N/A | $17.47 | -$1.72 |
| 2011 | N/A | N/A | $8.65 | -$2.64 |
| 2010 | N/A | N/A | N/A | -$47.29 |
Pacira BioSciences PE ratio by quarter (TTM)
| Year | PE ratio | PE change | Price | EPS |
|---|---|---|---|---|
| Jun 2025 | N/A | N/A | $23.9 | -$2.77 |
| Mar 2025 | N/A | N/A | $24.85 | -$2.25 |
| Dec 2024 | N/A | N/A | $18.84 | -$2.15 |
| Sep 2024 | N/A | N/A | $15.05 | -$1.97 |
| Jun 2024 | 20.88 | 8.64% | $28.61 | $1.37 |
| Mar 2024 | 19.22 | -48.17% | $29.22 | $1.52 |
| Dec 2023 | 37.08 | -83.08% | $33.74 | $0.91 |
| Sep 2023 | 219.14 | N/A | $30.68 | $0.14 |
| Jun 2023 | N/A | N/A | $40.07 | -$0.11 |
| Mar 2023 | N/A | N/A | $40.81 | -$0.23 |
| Dec 2022 | 110.31 | -6.68% | $38.61 | $0.35 |
| Sep 2022 | 118.2 | 76.39% | $53.19 | $0.45 |
| Jun 2022 | 67.01 | -24.49% | $58.3 | $0.87 |
| Mar 2022 | 88.74 | 40.1% | $76.32 | $0.86 |
| Dec 2021 | 63.34 | 57.21% | $60.17 | $0.95 |
PCRX Price vs fair value
PCRX average PE ratio chart
PE comparison
PCRX PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| HRTX Heron Therapeutics Inc | N/A | $203.53M |
| CPIX Cumberland Pharmaceuticals Inc | N/A | $34.86M |
| TVRD Tvardi Therapeutics Inc. | N/A | $39.57M |
| OMER Omeros Corp | N/A | $475.71M |
| PCRX Pacira BioSciences Inc | N/A | $981.78M |
Frequently asked questions
What is Pacira BioSciences's PE ratio?
The current price to earnings ratio of PCRX can't be calculated, as its EPS of -$2.77 is negative.
What is the 3-year average PE ratio for Pacira BioSciences (PCRX)?
The 3-year average PE ratio for PCRX stock is 81.33.
What is the 5-year average PE ratio for Pacira BioSciences (PCRX)?
The 5-year average PE ratio for PCRX stock is 64.41.
What is the highest PE ratio for PCRX?
The highest quarterly PE ratio in the last ten years has been 1,535.8 and it was in the Dec 2015 quarter.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified.